1.Coronado   VG, Xu   L, Basavaraju   SV, McGuire   LC, Wald   MM, Faul   MD, et al.  Surveillance for traumatic brain injury-related deaths--United States, 1997-2007. MMWR Surveill Summ. 2011;60:1–32.

2.Bazarian   JJ, Pope   C, McClung   J, Cheng   YT, Flesher   W. Ethnic and racial disparities in emergency department care for mild traumatic brain injury. Acad Emerg Med. 2003;10:1209–17.

3.Stubbs   JL, Thornton   AE, Sevick   JM, Silverberg   ND, Barr   AM, Honer   WG, et al.  Traumatic brain injury in homeless and marginally housed individuals: a systematic review and meta-analysis. Lancet Public Health. 2020;5:e19–32.

4.Farrer   TJ, Hedges   DW. Prevalence of traumatic brain injury in incarcerated groups compared to the general population: a meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35:390–4.

5.Koh   BI, Lee   HJ, Kwak   PA, Yang   MJ, Kim   JH, Kim   HS, et al.  VEGFR2 signaling drives meningeal vascular regeneration upon head injury. Nat Commun. 2020;11:3866.

6.Donovan   V, Bianchi   A, Hartman   R, Bhanu   B, Carson   MJ, Obenaus   A. Computational analysis reveals increased blood deposition following repeated mild traumatic brain injury. Neuroimage Clin. 2012;1:18–28.

7.Lynch   CE, Crynen   G, Ferguson   S, Mouzon   B, Paris   D, Ojo   J, et al.  Chronic cerebrovascular abnormalities in a mouse model of repetitive mild traumatic brain injury. Brain Inj. 2016;30:1414–27.

8.Sandsmark   DK, Bashir   A, Wellington   CL, Diaz-Arrastia   R. Cerebral microvascular injury: a potentially treatable Endophenotype of traumatic brain injury-induced neurodegeneration. Neuron. 2019;103:367–79.

9.Salehi   A, Zhang   JH, Obenaus   A. Response of the cerebral vasculature following traumatic brain injury. J Cereb Blood Flow Metab. 2017;37:2320–39.

10.Teasdale   G, Jennett   B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81–4.

11.Silverberg   ND, Duhaime   AC, Iaccarino   MA. Mild traumatic brain injury in 2019-2020. JAMA. 2020;323:177–8.

12.Benson   RR, Gattu   R, Sewick   B, Kou   Z, Zakariah   N, Cavanaugh   JM, et al.  Detection of hemorrhagic and axonal pathology in mild traumatic brain injury using advanced MRI: implications for neurorehabilitation. NeuroRehabilitation. 2012;31:261–79.

13.Konrad   C, Geburek   AJ, Rist   F, Blumenroth   H, Fischer   B, Husstedt   I, et al.  Long-term cognitive and emotional consequences of mild traumatic brain injury. Psychol Med. 2011;41:1197–211.

14.Maas   AI, Stocchetti   N, Bullock   R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728–41.

15.Goldstein   LE, Fisher   AM, Tagge   CA, Zhang   XL, Velisek   L, Sullivan   JA, et al.  Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012;4:134ra60.

16.Dietrich   WD, Alonso   O, Halley   M. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma. 1994;11:289–301.

17.Maxwell   WL, Irvine   A, Adams   JH, Graham   DI, Gennarelli   TA. Response of cerebral microvasculature to brain injury. J Pathol. 1988;155:327–35.

18.Kenney   K, Amyot   F, Haber   M, Pronger   A, Bogoslovsky   T, Moore   C, et al.  Cerebral vascular injury in traumatic brain injury. Exp Neurol. 2016;275:353–66.

19.Wang   AC, Charters   MA, Thawani   JP, Than   KD, Sullivan   SE, Graziano   GP. Evaluating the use and utility of noninvasive angiography in diagnosing traumatic blunt cerebrovascular injury. J Trauma Acute Care Surg. 2012;72:1601–10.

20.Mildenberger   W, Stifter   SA, Greter   M. Diversity and function of brain-associated macrophages. Curr Opin Immunol. 2022;76:102181.

21.Cugurra   A, Mamuladze   T, Rustenhoven   J, Dykstra   T, Beroshvili   G, Greenberg   ZJ, et al.  Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science. 2021;373:eabf7844. https://doi.org/10.1126/science.abf7844.

22.Roth   TL, Nayak   D, Atanasijevic   T, Koretsky   AP, Latour   LL, McGavern   DB. Transcranial amelioration of inflammation and cell death after brain injury. Nature. 2014;505:223–8.

23.Corsellis   JA, Brierley   JB. Observations on the pathology of insidious dementia following head injury. J Ment Sci. 1959;105:714–20.

24.Williams   WH, Potter   S, Ryland   H. Mild traumatic brain injury and Postconcussion syndrome: a neuropsychological perspective. J Neurol Neurosurg Psychiatry. 2010;81:1116–22.

25.Maegele   M, Schochl   H, Menovsky   T, Marechal   H, Marklund   N, Buki   A, et al.  Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. Lancet Neurol. 2017;16:630–47.

26.Perel   P, Roberts   I, Bouamra   O, Woodford   M, Mooney   J, Lecky   F. Intracranial bleeding in patients with traumatic brain injury: a prognostic study. BMC Emerg Med. 2009;9:15.

27.Lee   JJ, Segar   DJ, Morrison   JF, Mangham   WM, Lee   S, Asaad   WF. Subdural hematoma as a major determinant of short-term outcomes in traumatic brain injury. J Neurosurg. 2018;128:236–49.

28.Hochstadter   E, Stewart   TC, Alharfi   IM, Ranger   A, Fraser   DD. Subarachnoid hemorrhage prevalence and its association with short-term outcome in pediatric severe traumatic brain injury. Neurocrit Care. 2014;21:505–13.

29.Gaasch   JA, Lockman   PR, Geldenhuys   WJ, Allen   DD, Van der Schyf   CJ. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res. 2007;32:1196–208.

30.Glushakova   OY, Johnson   D, Hayes   RL. Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J Neurotrauma. 2014;31:1180–93.

31.Harhangi   BS, Kompanje   EJ, Leebeek   FW, Maas   AI. Coagulation disorders after traumatic brain injury. Acta Neurochir. 2008;150:165–75  discussion 75.

32.Midura   EF, Jernigan   PL, Kuethe   JW, Friend   LA, Veile   R, Makley   AT, et al.  Microparticles impact coagulation after traumatic brain injury. J Surg Res. 2015;197:25–31.

33.Laroche   M, Kutcher   ME, Huang   MC, Cohen   MJ, Manley   GT. Coagulopathy after traumatic brain injury. Neurosurgery. 2012;70:1334–45.

34.Schnuriger   B, Inaba   K, Abdelsayed   GA, Lustenberger   T, Eberle   BM, Barmparas   G, et al.  The impact of platelets on the progression of traumatic intracranial hemorrhage. J Trauma. 2010;68:881–5.

35.Bhowmick   S, D'Mello   V, Caruso   D, Wallerstein   A, Abdul-Muneer   PM. Impairment of pericyte-endothelium crosstalk leads to blood-brain barrier dysfunction following traumatic brain injury. Exp Neurol. 2019;317:260–70.

36.Cash   A, Theus   MH. Mechanisms of blood-brain barrier dysfunction in traumatic brain injury. Int J Mol Sci. 2020;21:3344. https://doi.org/10.3390/ijms21093344.

37.Rinder   L, Olsson   Y. Studies on vascular permeability changes in experimental brain concussion. I. Distribution of circulating fluorescent indicators in brain and cervical cord after sudden mechanical loading of the brain. Acta Neuropathol. 1968;11:183–200.

38.Hekmatpanah   J, Hekmatpanah   CR. Microvascular alterations following cerebral contusion in rats. Light, scanning, and electron microscope study. J Neurosurg. 1985;62:888–97.

39.Donkin   JJ, Vink   R. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments. Curr Opin Neurol. 2010;23:293–9.

40.Yeoh   S, Bell   ED, Monson   KL. Distribution of blood-brain barrier disruption in primary blast injury. Ann Biomed Eng. 2013;41:2206–14.

41.Hawkins   BT, Davis   TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173–85.

42.Keaney   J, Campbell   M. The dynamic blood-brain barrier. FEBS J. 2015;282:4067–79.

43.Ho   KM, Honeybul   S, Yip   CB, Silbert   BI. Prognostic significance of blood-brain barrier disruption in patients with severe nonpenetrating traumatic brain injury requiring decompressive craniectomy. J Neurosurg. 2014;121:674–9.

44.Tomkins   O, Shelef   I, Kaizerman   I, Eliushin   A, Afawi   Z, Misk   A, et al.  Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry. 2008;79:774–7.

45.Habgood   MD, Bye   N, Dziegielewska   KM, Ek   CJ, Lane   MA, Potter   A, et al.  Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice. Eur J Neurosci. 2007;25:231–8.

46.Marmarou   A. Pathophysiology of traumatic brain edema: current concepts. Acta Neurochir Suppl. 2003;86:7–10.

47.Badaut   J, Ashwal   S, Obenaus   A. Aquaporins in cerebrovascular disease: a target for treatment of brain edema?  Cerebrovasc Dis. 2011;31:521–31.

48.Nirula   R, Millar   D, Greene   T, McFadden   M, Shah   L, Scalea   TM, et al.  Decompressive craniectomy or medical management for refractory intracranial hypertension: an AAST-MIT propensity score analysis. J Trauma Acute Care Surg. 2014;76:944–52  discussion 52-5.

49.Barzo   P, Marmarou   A, Fatouros   P, Hayasaki   K, Corwin   F. Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg. 1997;87:900–7.

50.Hanstock   CC, Faden   AI, Bendall   MR, Vink   R. Diffusion-weighted imaging differentiates ischemic tissue from traumatized tissue. Stroke. 1994;25:843–8.

51.Mestre   H, Du   T, Sweeney   AM, Liu   G, Samson   AJ, Peng   W, et al.  Cerebrospinal fluid influx drives acute ischemic tissue swelling. Science. 2020;367:eaax7171.

52.Bouma   GJ, Muizelaar   JP, Stringer   WA, Choi   SC, Fatouros   P, Young   HF. Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J Neurosurg. 1992;77:360–8.

53.Soustiel   JF, Glenn   TC, Shik   V, Boscardin   J, Mahamid   E, Zaaroor   M. Monitoring of cerebral blood flow and metabolism in traumatic brain injury. J Neurotrauma. 2005;22:955–65.

54.del  Zoppo   GJ, Higashida   RT, Furlan   AJ, Pessin   MS, Rowley   HA, Gent   M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism. Stroke. 1998;29:4–11.

55.Ostergaard   L, Engedal   TS, Aamand   R, Mikkelsen   R, Iversen   NK, Anzabi   M, et al.  Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury. J Cereb Blood Flow Metab. 2014;34:1585–98.

56.Doshi   H, Wiseman   N, Liu   J, Wang   W, Welch   RD, O'Neil   BJ, et al.  Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage. PLoS One. 2015;10:e0118061.

57.Albrecht   JS, Liu   X, Smith   GS, Baumgarten   M, Rattinger   GB, Gambert   SR, et al.  Stroke incidence following traumatic brain injury in older adults. J Head Trauma Rehabil. 2015;30:E62–7.

58.Chen   YH, Kang   JH, Lin   HC. Patients with traumatic brain injury: population-based study suggests increased risk of stroke. Stroke. 2011;42:2733–9.

59.Liao   CC, Chou   YC, Yeh   CC, Hu   CJ, Chiu   WT, Chen   TL. Stroke risk and outcomes in patients with traumatic brain injury: 2 nationwide studies. Mayo Clin Proc. 2014;89:163–72.

60.Launey   Y, Fryer   TD, Hong   YT, Steiner   LA, Nortje   J, Veenith   TV, et al.  Spatial and temporal pattern of ischemia and abnormal vascular function following traumatic brain injury. JAMA Neurol. 2020;77:339–49.

61.Veenith   TV, Carter   EL, Geeraerts   T, Grossac   J, Newcombe   VF, Outtrim   J, et al.  Pathophysiologic mechanisms of cerebral ischemia and diffusion hypoxia in traumatic brain injury. JAMA Neurol. 2016;73:542–50.

62.Vespa   PM. Brain hypoxia and ischemia after traumatic brain injury: is oxygen the right metabolic target?  JAMA Neurol. 2016;73:504–5.

63.Budohoski   KP, Czosnyka   M, de  Riva   N, Smielewski   P, Pickard   JD, Menon   DK, et al.  The relationship between cerebral blood flow autoregulation and cerebrovascular pressure reactivity after traumatic brain injury. Neurosurgery. 2012;71:652–60  discussion 60-1.

64.Czosnyka   M, Smielewski   P, Kirkpatrick   P, Menon   DK, Pickard   JD. Monitoring of cerebral autoregulation in head-injured patients. Stroke. 1996;27:1829–34.

65.Czosnyka   M, Smielewski   P, Piechnik   S, Steiner   LA, Pickard   JD. Cerebral autoregulation following head injury. J Neurosurg. 2001;95:756–63.

66.Johnson   U, Nilsson   P, Ronne-Engstrom   E, Howells   T, Enblad   P. Favorable outcome in traumatic brain injury patients with impaired cerebral pressure autoregulation when treated at low cerebral perfusion pressure levels. Neurosurgery. 2011;68:714–21  discussion 21-2.

67.Kramer   DR, Winer   JL, Pease   BA, Amar   AP, Mack   WJ. Cerebral vasospasm in traumatic brain injury. Neurol Res Int. 2013;2013:1–7.

68.Oertel   M, Boscardin   WJ, Obrist   WD, Glenn   TC, McArthur   DL, Gravori   T, et al.  Posttraumatic vasospasm: the epidemiology, severity, and time course of an underestimated phenomenon: a prospective study performed in 299 patients. J Neurosurg. 2005;103:812–24.

69.Alford   PW, Dabiri   BE, Goss   JA, Hemphill   MA, Brigham   MD, Parker   KK. Blast-induced phenotypic switching in cerebral vasospasm. Proc Natl Acad Sci U S A. 2011;108:12705–10.

70.Izzy   S, Muehlschlegel   S. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage and traumatic brain injury. Curr Treat Options Neurol. 2014;16:278.

71.Dore-Duffy   P, Owen   C, Balabanov   R, Murphy   S, Beaumont   T, Rafols   JA. Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res. 2000;60:55–69.

72.Park   E, Bell   JD, Siddiq   IP, Baker   AJ. An analysis of regional microvascular loss and recovery following two grades of fluid percussion trauma: a role for hypoxia-inducible factors in traumatic brain injury. J Cereb Blood Flow Metab. 2009;29:575–84.

73.Siddiq   I, Park   E, Liu   E, Spratt   SK, Surosky   R, Lee   G, et al.  Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-A. J Neurotrauma. 2012;29:2647–59.

74.Quintard   H, Heurteaux   C, Ichai   C. Adult neurogenesis and brain remodelling after brain injury: from bench to bedside?  Anaesth Crit Care Pain Med. 2015;34:239–45.

75.Greenberg   DA, Jin   K. From angiogenesis to neuropathology. Nature. 2005;438:954–9.

76.Risau   W. Mechanisms of angiogenesis. Nature. 1997;386:671–4.

77.Skold   MK, von  Gertten   C, Sandberg-Nordqvist   AC, Mathiesen   T, Holmin   S. VEGF and VEGF receptor expression after experimental brain contusion in rat. J Neurotrauma. 2005;22:353–67.

78.Shore   PM, Jackson   EK, Wisniewski   SR, Clark   RS, Adelson   PD, Kochanek   PM. Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children. Neurosurgery. 2004;54:605–11  discussion 11-2.

79.Ju   S, Xu   C, Wang   G, Zhang   L. VEGF-C induces alternative activation of microglia to promote recovery from traumatic brain injury. J Alzheimers Dis. 2019;68:1687–97.

80.Ma   X, Agas   A, Siddiqui   Z, Kim   K, Iglesias-Montoro   P, Kalluru   J, et al.  Angiogenic peptide hydrogels for treatment of traumatic brain injury. Bioact Mater. 2020;5:124–32.

81.Zhang   Y, Xu   B, Chen   Q, Yan   Y, Du   J, Du   X. Apoptosis of endothelial cells contributes to brain vessel pruning of zebrafish during development. Front Mol Neurosci. 2018;11:222.

82.Alves   JL. Blood-brain barrier and traumatic brain injury. J Neurosci Res. 2014;92:141–7.

83.Chodobski   A, Zink   BJ, Szmydynger-Chodobska   J. Blood-brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res. 2011;2:492–516.

84.Charkviani   M, Muradashvili   N, Lominadze   D. Vascular and non-vascular contributors to memory reduction during traumatic brain injury. Eur J Neurosci. 2019;50:2860–76.

85.Eliceiri   BP, Paul   R, Schwartzberg   PL, Hood   JD, Leng   J, Cheresh   DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell. 1999;4:915–24.

86.Heymans   S, Luttun   A, Nuyens   D, Theilmeier   G, Creemers   E, Moons   L, et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med. 1999;5:1135–42.

87.Eelen   G, de  Zeeuw   P, Simons   M, Carmeliet   P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 2015;116:1231–44.

88.Potente   M, Gerhardt   H, Carmeliet   P. Basic and therapeutic aspects of angiogenesis. Cell. 2011;146:873–87.

89.Mazzone   M, Dettori   D, de  Oliveira   RL, Loges   S, Schmidt   T, Jonckx   B, et al.  Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009;136:839–51.

90.Komarova   YA, Kruse   K, Mehta   D, Malik   AB. Protein interactions at endothelial junctions and Signaling mechanisms regulating endothelial permeability. Circ Res. 2017;120:179–206.

91.Schneeberger   EE, Lynch   RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286:C1213–28.

92.Hu   X, De Silva   TM, Chen   J, Faraci   FM. Cerebral vascular disease and neurovascular injury in ischemic stroke. Circ Res. 2017;120:449–71.

93.Kempuraj   D, Ahmed   ME, Selvakumar   GP, Thangavel   R, Raikwar   SP, Zaheer   SA, et al.  Mast cell activation, Neuroinflammation, and tight junction protein derangement in acute traumatic brain injury. Mediat Inflamm. 2020;2020:4243953.

94.Carmeliet   P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–95.

95.Boroujerdi   A, Welser-Alves   JV, Milner   R. Matrix metalloproteinase-9 mediates post-hypoxic vascular pruning of cerebral blood vessels by degrading laminin and claudin-5. Angiogenesis. 2015;18:255–64.

96.Adams   RH, Alitalo   K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8:464–78.

97.Herbert   SP, Stainier   DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol. 2011;12:551–64.

98.Korn   C, Augustin   HG. Mechanisms of vessel pruning and regression. Dev Cell. 2015;34:5–17.

99.Betz   C, Lenard   A, Belting   HG, Affolter   M. Cell behaviors and dynamics during angiogenesis. Development. 2016;143:2249–60.

100.Kochhan   E, Lenard   A, Ellertsdottir   E, Herwig   L, Affolter   M, Belting   HG, et al.  Blood flow changes coincide with cellular rearrangements during blood vessel pruning in zebrafish embryos. PLoS One. 2013;8:e75060.

101.Franco   CA, Jones   ML, Bernabeu   MO, Geudens   I, Mathivet   T, Rosa   A, et al.  Dynamic endothelial cell rearrangements drive developmental vessel regression. PLoS Biol. 2015;13:e1002125.

102.Lobov   IB, Rao   S, Carroll   TJ, Vallance   JE, Ito   M, Ondr   JK, et al.  WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature. 2005;437:417–21.

103.Liu   L, Wei   H, Chen   F, Wang   J, Dong   JF, Zhang   J. Endothelial progenitor cells correlate with clinical outcome of traumatic brain injury. Crit Care Med. 2011;39:1760–5.

104.Wei   HJ, Liu   L, Chen   FL, Wang   D, Wang   L, Wang   ZG, et al.  Decreased numbers of circulating endothelial progenitor cells are associated with hyperglycemia in patients with traumatic brain injury. Neural Regen Res. 2019;14:984–90.

105.Liu   L, Liu   H, Jiao   J, Liu   H, Bergeron   A, Dong   JF, et al.  Changes in circulating human endothelial progenitor cells after brain injury. J Neurotrauma. 2007;24:936–43.

106.Guo   X, Liu   L, Zhang   M, Bergeron   A, Cui   Z, Dong   JF, et al.  Correlation of CD34+ cells with tissue angiogenesis after traumatic brain injury in a rat model. J Neurotrauma. 2009;26:1337–44.

107.Asahara   T, Murohara   T, Sullivan   A, Silver   M, van der  Zee   R, Li   T, et al.  Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7.

108.Kawamoto   A, Gwon   HC, Iwaguro   H, Yamaguchi   JI, Uchida   S, Masuda   H, et al.  Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634–7.

109.Britten   MB, Abolmaali   ND, Assmus   B, Lehmann   R, Honold   J, Schmitt   J, et al.  Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003;108:2212–8.

110.Schachinger   V, Assmus   B, Britten   MB, Honold   J, Lehmann   R, Teupe   C, et al.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol. 2004;44:1690–9.

111.Matsumura   M, Fukuda   N, Kobayashi   N, Umezawa   H, Takasaka   A, Matsumoto   T, et al.  Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. J Atheroscler Thromb. 2009;16:319–26.

112.Kalka   C, Masuda   H, Takahashi   T, Kalka-Moll   WM, Silver   M, Kearney   M, et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422–7.

113.Takahashi   T, Kalka   C, Masuda   H, Chen   D, Silver   M, Kearney   M, et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434–8.

114.Li   Z, Wang   B, Kan   Z, Zhang   B, Yang   Z, Chen   J, et al.  Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats. J Neurotrauma. 2012;29:343–53.

115.Wang   B, Sun   L, Tian   Y, Li   Z, Wei   H, Wang   D, et al.  Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats. J Neurol Sci. 2012;319:117–23.

116.Yip   HK, Tsai   TH, Lin   HS, Chen   SF, Sun   CK, Leu   S, et al.  Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke. Crit Care. 2011;15:R40.

117.Ran   QS, Yu   YH, Fu   XH, Wen   YC. Activation of the notch signaling pathway promotes neurovascular repair after traumatic brain injury. Neural Regen Res. 2015;10:1258–64.

118.Ma   F, Morancho   A, Montaner   J, Rosell   A. Endothelial progenitor cells and revascularization following stroke. Brain Res. 2015;1623:150–9.

119.Senger   DR, Perruzzi   CA, Feder   J, Dvorak   HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 1986;46:5629–32.

120.Connolly   DT, Heuvelman   DM, Nelson   R, Olander   JV, Eppley   BL, Delfino   JJ, et al.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470–8.

121.Leung   DW, Cachianes   G, Kuang   WJ, Goeddel   DV, Ferrara   N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306–9.

122.Asahara   T, Takahashi   T, Masuda   H, Kalka   C, Chen   D, Iwaguro   H, et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964–72.

123.Hattori   K, Dias   S, Heissig   B, Hackett   NR, Lyden   D, Tateno   M, et al.  Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001;193:1005–14.

124.Fernandez-Klett   F, Offenhauser   N, Dirnagl   U, Priller   J, Lindauer   U. Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain. Proc Natl Acad Sci U S A. 2010;107:22290–5.

125.Hall   CN, Reynell   C, Gesslein   B, Hamilton   NB, Mishra   A, Sutherland   BA, et al.  Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 2014;508:55–60.

126.Armulik   A, Genove   G, Mae   M, Nisancioglu   MH, Wallgard   E, Niaudet   C, et al.  Pericytes regulate the blood-brain barrier. Nature. 2010;468:557–61.

127.Daneman   R, Zhou   L, Kebede   AA, Barres   BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468:562–6.

128.Chan-Ling   T, Page   MP, Gardiner   T, Baxter   L, Rosinova   E, Hughes   S. Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity. Am J Pathol. 2004;165:1301–13.

129.Cheng   J, Korte   N, Nortley   R, Sethi   H, Tang   Y, Attwell   D. Targeting pericytes for therapeutic approaches to neurological disorders. Acta Neuropathol. 2018;136:507–23.

130.Raza   A, Franklin   MJ, Dudek   AZ. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol. 2010;85:593–8.

131.Bergers   G, Song   S. The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncology. 2005;7:452–64.

132.Zehendner   CM, Sebastiani   A, Hugonnet   A, Bischoff   F, Luhmann   HJ, Thal   SC. Traumatic brain injury results in rapid pericyte loss followed by reactive pericytosis in the cerebral cortex. Sci Rep. 2015;5:13497.

133.Dore-Duffy   P, Wang   X, Mehedi   A, Kreipke   CW, Rafols   JA. Differential expression of capillary VEGF isoforms following traumatic brain injury. Neurol Res. 2007;29:395–403.

134.Yemisci   M, Gursoy-Ozdemir   Y, Vural   A, Can   A, Topalkara   K, Dalkara   T. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med. 2009;15:1031–7.

135.Hong   H, Tian   XY. The role of macrophages in vascular repair and regeneration after ischemic injury. Int J Mol Sci. 2020;21:6328. https://doi.org/10.3390/ijms21176328.

136.la  Sala   A, Pontecorvo   L, Agresta   A, Rosano   G, Stabile   E. Regulation of collateral blood vessel development by the innate and adaptive immune system. Trends Mol Med. 2012;18:494–501.

137.Nakayama   T, Kurobe   H, Sugasawa   N, Kinoshita   H, Higashida   M, Matsuoka   Y, et al.  Role of macrophage-derived hypoxia-inducible factor (HIF)-1alpha as a mediator of vascular remodelling. Cardiovasc Res. 2013;99:705–15.

138.Hsieh   CL, Kim   CC, Ryba   BE, Niemi   EC, Bando   JK, Locksley   RM, et al.  Traumatic brain injury induces macrophage subsets in the brain. Eur J Immunol. 2013;43:2010–22.

139.Huber-Lang   M, Lambris   JD, Ward   PA. Innate immune responses to trauma. Nat Immunol. 2018;19:327–41.

140.Jetten   N, Verbruggen   S, Gijbels   MJ, Post   MJ, De Winther   MP, Donners   MM. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 2014;17:109–18.

141.Spiller   KL, Anfang   RR, Spiller   KJ, Ng   J, Nakazawa   KR, Daulton   JW, et al.  The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials. 2014;35:4477–88.

142.He   H, Mack   JJ, Guc   E, Warren   CM, Squadrito   ML, Kilarski   WW, et al.  Perivascular macrophages limit permeability. Arterioscler Thromb Vasc Biol. 2016;36:2203–12.

143.Zhang   Z, Zhang   ZY, Wu   Y, Schluesener   HJ. Lesional accumulation of CD163+ macrophages/microglia in rat traumatic brain injury. Brain Res. 2012;1461:102–10.

144.Mastorakos   P, Russo   MV, Zhou   T, Johnson   K, McGavern   DB. Antimicrobial immunity impedes CNS vascular repair following brain injury. Nat Immunol. 2021;22:1280–93.

145.Da Mesquita   S, Fu   Z, Kipnis   J. The meningeal lymphatic system: a new player in neurophysiology. Neuron. 2018;100:375–88.

146.Aspelund   A, Antila   S, Proulx   ST, Karlsen   TV, Karaman   S, Detmar   M, et al.  A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212:991–9.

147.Louveau   A, Smirnov   I, Keyes   TJ, Eccles   JD, Rouhani   SJ, Peske   JD, et al.  Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337–41.

148.Ahn   JH, Cho   H, Kim   JH, Kim   SH, Ham   JS, Park   I, et al.  Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature. 2019;572:62–6.

149.Rustenhoven   J, Drieu   A, Mamuladze   T, de  Lima   KA, Dykstra   T, Wall   M, et al.  Functional characterization of the dural sinuses as a neuroimmune interface. Cell. 2021;184:1000–16 e27.

150.Da Mesquita   S, Louveau   A, Vaccari   A, Smirnov   I, Cornelison   RC, Kingsmore   KM, et al.  Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature. 2018;560:185–91.

151.Liao   J, Zhang   M, Shi   Z, Lu   H, Wang   L, Fan   W, et al.  Improving the function of meningeal lymphatic vessels to promote brain edema absorption after TBI. J Neurotrauma. 2023;40:383–94.

152.Loane   DJ, Faden   AI. Traumatic meningeal injury and repair mechanisms. Nat Immunol. 2018;19:431–2.

153.Bolte   AC, Dutta   AB, Hurt   ME, Smirnov   I, Kovacs   MA, McKee   CA, et al.  Meningeal lymphatic dysfunction exacerbates traumatic brain injury pathogenesis. Nat Commun. 2020;11:4524.

154.Meng   FW, Yu   JT, Chen   JY, Yang   PF. New lymphatic cell formation is associated with damaged brain tissue clearance after penetrating traumatic brain injury. Sci Rep. 2021;11:10193.

155.Chen   J, He   J, Ni   R, Yang   Q, Zhang   Y, Luo   L. Cerebrovascular injuries induce lymphatic invasion into brain parenchyma to guide vascular regeneration in zebrafish. Dev Cell. 2019;49:697–710.e5.

156.Mauri   C, van  Impel   A, Mackay   EW, Schulte-Merker   S. The adaptor protein Grb2b is an essential modulator for lympho-venous sprout formation in the zebrafish trunk. Angiogenesis. 2021;24:345–62.

157.Ransohoff   RM, Cardona   AE. The myeloid cells of the central nervous system parenchyma. Nature. 2010;468:253–62.

158.Prinz   M, Priller   J, Sisodia   SS, Ransohoff   RM. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci. 2011;14:1227–35.

159.Prinz   M, Priller   J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci. 2014;15:300–12.

160.Goldmann   T, Wieghofer   P, Jordao   MJ, Prutek   F, Hagemeyer   N, Frenzel   K, et al.  Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol. 2016;17:797–805.

161.Russo   MV, Latour   LL, McGavern   DB. Distinct myeloid cell subsets promote meningeal remodeling and vascular repair after mild traumatic brain injury. Nat Immunol. 2018;19:442–52.

162.Schledzewski   K, Falkowski   M, Moldenhauer   G, Metharom   P, Kzhyshkowska   J, Ganss   R, et al.  Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol. 2006;209:67–77.

163.Cho   CH, Koh   YJ, Han   J, Sung   HK, Jong Lee   H, Morisada   T, et al.  Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ Res. 2007;100:e47–57.

164.Davalos   D, Grutzendler   J, Yang   G, Kim   JV, Zuo   Y, Jung   S, et al.  ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8:752–8.

165.Kim   JV, Dustin   ML. Innate response to focal necrotic injury inside the blood-brain barrier. J Immunol. 2006;177:5269–77.

166.Zhao   Z-A, Li   P, Ye   S-Y, Ning   Y-L, Wang   H, Peng   Y, et al.  Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation. Sci Rep. 2017;7:2254.

167.Bush   TG, Puvanachandra   N, Horner   CH, Polito   A, Ostenfeld   T, Svendsen   CN, et al.  Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron. 1999;23:297–308.

168.Argaw   AT, Gurfein   BT, Zhang   Y, Zameer   A, John   GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A. 2009;106:1977–82.

169.Argaw   AT, Asp   L, Zhang   J, Navrazhina   K, Pham   T, Mariani   JN, et al.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest. 2012;122:2454–68.

170.Bell   RD, Winkler   EA, Singh   I, Sagare   AP, Deane   R, Wu   Z, et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin a. Nature. 2012;485:512–6.

171.Alvarez   JI, Dodelet-Devillers   A, Kebir   H, Ifergan   I, Fabre   PJ, Terouz   S, et al.  The hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science. 2011;334:1727–31.

172.Alvarez   JI, Katayama   T, Prat   A. Glial influence on the blood brain barrier. Glia. 2013;61:1939–58.

173.Mizee   MR, Nijland   PG, van der  Pol   SM, Drexhage   JA, van Het  Hof   B, Mebius   R, et al.  Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis. Acta Neuropathol. 2014;128:691–703.

174.Papadopoulos   MC, Verkman   AS. Aquaporin water channels in the nervous system. Nat Rev Neurosci. 2013;14:265–77.

175.Burda   JE, Bernstein   AM, Sofroniew   MV. Astrocyte roles in traumatic brain injury. Exp Neurol. 2016;275:305–15.

176.Chen   HH, Chien   CH, Liu   HM. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke. 1994;25:1651–7.

177.Wei   L, Erinjeri   JP, Rovainen   CM, Woolsey   TA. Collateral growth and angiogenesis around cortical stroke. Stroke. 2001;32:2179–84.

178.Jander   S, Schroeter   M, D'Urso   D, Gillen   C, Witte   OW, Stoll   G. Focal ischaemia of the rat brain elicits an unusual inflammatory response: early appearance of CD8+ macrophages/microglia. Eur J Neurosci. 1998;10:680–8.

179.Manoonkitiwongsa   PS, Jackson-Friedman   C, McMillan   PJ, Schultz   RL, Lyden   PD. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J Cereb Blood Flow Metab. 2001;21:1223–31.

180.Medina   RJ, O'Neill   CL, O'Doherty   TM, Knott   H, Guduric-Fuchs   J, Gardiner   TA, et al.  Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Mol Med. 2011;17:1045–55.

181.Zajac   E, Schweighofer   B, Kupriyanova   TA, Juncker-Jensen   A, Minder   P, Quigley   JP, et al.  Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood. 2013;122:4054–67.

182.Welser   JV, Li   L, Milner   R. Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-beta1. J Neuroinflammation. 2010;7:89.

183.Jin   Q, Cheng   J, Liu   Y, Wu   J, Wang   X, Wei   S, et al.  Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke. Brain Behav Immun. 2014;40:131–42.

184.Loane   DJ, Kumar   A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp Neurol. 2016;275:316–27.

185.Mukouyama   YS, Shin   D, Britsch   S, Taniguchi   M, Anderson   DJ. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell. 2002;109:693–705.

186.Lambrechts   D, Storkebaum   E, Morimoto   M, Del-Favero   J, Desmet   F, Marklund   SL, et al.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003;34:383–94.

187.Lu   X, Le Noble   F, Yuan   L, Jiang   Q, De Lafarge   B, Sugiyama   D, et al.  The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature. 2004;432:179–86.

188.Okabe   K, Kobayashi   S, Yamada   T, Kurihara   T, Tai-Nagara   I, Miyamoto   T, et al.  Neurons limit angiogenesis by titrating VEGF in retina. Cell. 2014;159:584–96.

189.Parent   JM, Vexler   ZS, Gong   C, Derugin   N, Ferriero   DM. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol. 2002;52:802–13.

190.Kojima   T, Hirota   Y, Ema   M, Takahashi   S, Miyoshi   I, Okano   H, et al.  Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum. Stem Cells. 2010;28:545–54.

191.Skardelly   M, Gaber   K, Burdack   S, Scheidt   F, Hilbig   H, Boltze   J, et al.  Long-term benefit of human fetal neuronal progenitor cell transplantation in a clinically adapted model after traumatic brain injury. J Neurotrauma. 2011;28:401–14.

192.Schiera   G, Proia   P, Alberti   C, Mineo   M, Savettieri   G, Di Liegro   I. Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles. J Cell Mol Med. 2007;11:1384–94.

193.Addington   CP, Roussas   A, Dutta   D, Stabenfeldt   SE. Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration. Biomark Insights. 2015;10:43–60.

194.Benelli   R, Lorusso   G, Albini   A, Noonan   DM. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des. 2006;12:3101–15.

195.Hanahan   D. Signaling vascular morphogenesis and maintenance. Science. 1997;277:48–50.

196.Hamada   K, Oike   Y, Takakura   N, Ito   Y, Jussila   L, Dumont   DJ, et al.  VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood. 2000;96:3793–800.

197.Koch   S, Claesson-Welsh   L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med. 2012;2:a006502.

198.Ferrara   N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581–611.

199.Asahara   T, Masuda   H, Takahashi   T, Kalka   C, Pastore   C, Silver   M, et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221–8.

200.Sun   M, Baker   TL, Wilson   CT, Brady   RD, Mychasiuk   R, Yamakawa   GR, et al.  Treatment with vascular endothelial growth factor-a worsens cognitive recovery in a rat model of mild traumatic brain injury. Front Mol Neurosci. 2022;15:937350.

201.Croll   SD, Ransohoff   RM, Cai   N, Zhang   Q, Martin   FJ, Wei   T, et al.  VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol. 2004;187:388–402.

202.Goetz   R, Mohammadi   M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013;14:166–80.

203.Wang   ZG, Cheng   Y, Yu   XC, Ye   LB, Xia   QH, Johnson   NR, et al.  bFGF protects against blood-brain barrier damage through junction protein regulation via PI3K-Akt-Rac1 pathway following traumatic brain injury. Mol Neurobiol. 2016;53:7298–311.

204.Huang   B, Krafft   PR, Ma   Q, Rolland   WB, Caner   B, Lekic   T, et al.  Fibroblast growth factors preserve blood-brain barrier integrity through RhoA inhibition after intracerebral hemorrhage in mice. Neurobiol Dis. 2012;46:204–14.

205.Rundhaug   JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9:267–85.

206.Cabral-Pacheco   GA, Garza-Veloz   I, Castruita-De la Rosa   C, Ramirez-Acuna   JM, Perez-Romero   BA, Guerrero-Rodriguez   JF, et al.  The roles of matrix Metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21:9739.

207.Delafontaine   P, Song   YH, Li   Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol. 2004;24:435–44.

208.Armulik   A, Genove   G, Betsholtz   C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21:193–215.

209.Goumans   MJ, Valdimarsdottir   G, Itoh   S, Lebrin   F, Larsson   J, Mummery   C, et al.  Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell. 2003;12:817–28.

210.Goumans   MJ, Lebrin   F, Valdimarsdottir   G. Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med. 2003;13:301–7.

211.Goumans   MJ, Ten Dijke   P. TGF-β Signaling in control of cardiovascular function. Cold Spring Harb Perspect Biol. 2018;10:a022210. https://doi.org/10.1101/cshperspect.a022210.

212.Wang   L, Chopp   M, Teng   H, Bolz   M, Francisco   MA, Aluigi   DM, et al.  Tumor necrosis factor alpha primes cerebral endothelial cells for erythropoietin-induced angiogenesis. J Cereb Blood Flow Metab. 2011;31:640–7.

213.Leibovich   SJ, Polverini   PJ, Shepard   HM, Wiseman   DM, Shively   V, Nuseir   N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature. 1987;329:630–2.

214.Prisco   AR, Hoffmann   BR, Kaczorowski   CC, McDermott-Roe   C, Stodola   TJ, Exner   EC, et al.  Tumor necrosis factor alpha regulates endothelial progenitor cell migration via CADM1 and NF-kB. Stem Cells. 2016;34:1922–33.

215.Yamamoto   N, Oyaizu   T, Enomoto   M, Horie   M, Yuasa   M, Okawa   A, et al.  VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration. Sci Rep. 2020;10:2744.

216.Deininger   MH, Wybranietz   WA, Graepler   FT, Lauer   UM, Meyermann   R, Schluesener   HJ. Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. FASEB J. 2003;17:1267–76.

217.Sunshine   SB, Dallabrida   SM, Durand   E, Ismail   NS, Bazinet   L, Birsner   AE, et al.  Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition. Proc Natl Acad Sci U S A. 2012;109:11306–11.

218.Simao   F, Pagnussat   AS, Seo   JH, Navaratna   D, Leung   W, Lok   J, et al.  Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J Cereb Blood Flow Metab. 2012;32:884–95.

219.Mayer   B, John   M, Bohme   E. Purification of a Ca2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin. FEBS Lett. 1990;277:215–9.

220.Schmidt   HH, Pollock   JS, Nakane   M, Gorsky   LD, Forstermann   U, Murad   F. Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc Natl Acad Sci U S A. 1991;88:365–9.

221.Bredt   DS, Snyder   SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682–5.

222.Chen   J, Cui   X, Zacharek   A, Roberts   C, Chopp   M. eNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in mice. Stroke. 2009;40:2532–8.

223.Lee   CZ, Xue   Z, Hao   Q, Yang   GY, Young   WL. Nitric oxide in vascular endothelial growth factor-induced focal angiogenesis and matrix metalloproteinase-9 activity in the mouse brain. Stroke. 2009;40:2879–81.

224.Ley   K, Laudanna   C, Cybulsky   MI, Nourshargh   S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678–89.

225.Wittchen   ES. Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci (Landmark Ed). 2009;14:2522–45.

226.Dirkx   AE, Oude Egbrink   MG, Wagstaff   J, Griffioen   AW. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol. 2006;80:1183–96.

227.Schlesinger   M, Bendas   G. Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis. Int J Cancer. 2015;136:2504–14.

228.Koch   AE, Halloran   MM, Haskell   CJ, Shah   MR, Polverini   PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 1995;376:517–9.

229.Kurland   DB, Tosun   C, Pampori   A, Karimy   JK, Caffes   NM, Gerzanich   V, et al.  Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals (Basel). 2013;6:1287–303.

230.Vasa   M, Fichtlscherer   S, Aicher   A, Adler   K, Urbich   C, Martin   H, et al.  Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1–7.

231.Ding   G, Jiang   Q, Li   L, Zhang   L, Zhang   ZG, Ledbetter   KA, et al.  Magnetic resonance imaging investigation of axonal remodeling and angiogenesis after embolic stroke in sildenafil-treated rats. J Cereb Blood Flow Metab. 2008;28:1440–8.

232.Li   L, Jiang   Q, Zhang   L, Ding   G, Gang Zhang   Z, Li   Q, et al.  Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. Brain Res. 2007;1132:185–92.

233.Zhang   R, Wang   Y, Zhang   L, Zhang   Z, Tsang   W, Lu   M, et al.  Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke. 2002;33:2675–80.

234.Grammas   P, Martinez   J, Sanchez   A, Yin   X, Riley   J, Gay   D, et al.  A new paradigm for the treatment of Alzheimer's disease: targeting vascular activation. J Alzheimers Dis. 2014;40:619–30.

235.Guo   XB, Deng   X, Wei   Y. Homing of cultured endothelial progenitor cells and their effect on traumatic brain injury in rat model. Sci Rep. 2017;7:4164.

236.Huang   XT, Zhang   YQ, Li   SJ, Li   SH, Tang   Q, Wang   ZT, et al.  Intracerebroventricular transplantation of ex vivo expanded endothelial colony-forming cells restores blood-brain barrier integrity and promotes angiogenesis of mice with traumatic brain injury. J Neurotrauma. 2013;30:2080–8.

237.Li   Z, Xiao   J, Xu   X, Li   W, Zhong   R, Qi   L, et al.  M-CSF, IL-6, and TGF-β promote generation of a new subset of tissue repair macrophage for traumatic brain injury recovery. Sci Adv. 2021;7:eabb6260. https://doi.org/10.1126/sciadv.abb6260.

238.Lu   J, Guan   F, Cui   F, Sun   X, Zhao   L, Wang   Y, et al.  Enhanced angiogenesis by the hyaluronic acid hydrogels immobilized with a VEGF mimetic peptide in a traumatic brain injury model in rats. Regen Biomater. 2019;6:325–34.

239.Thau-Zuchman   O, Shohami   E, Alexandrovich   AG, Leker   RR. Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury. J Mol Neurosci. 2012;47:166–72.

240.Gan   ZS, Stein   SC, Swanson   R, Guan   S, Garcia   L, Mehta   D, et al.  Blood biomarkers for traumatic brain injury: a quantitative assessment of diagnostic and prognostic accuracy. Front Neurol. 2019;10:446.

241.Zetterberg   H, Blennow   K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol. 2016;12:563–74.

242.Brouns   R, Wauters   A, De Surgeloose   D, Marien   P, De Deyn   PP. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol. 2011;65:23–31.

243.Cummins   PM. Occludin: one protein, many forms. Mol Cell Biol. 2012;32:242–50.

244.Baker   TL, Agoston   DV, Brady   RD, Major   B, McDonald   SJ, Mychasiuk   R, et al.  Targeting the cerebrovascular system: next-generation biomarkers and treatment for mild traumatic brain injury. Neuroscientist. 2022;28:594–612.

245.Battaglini   D, Siwicka-Gieroba   D, Rocco   PR, Cruz   FF, Silva   PL, Dabrowski   W, et al.  Novel synthetic and natural therapies for traumatic brain injury. Curr Neuropharmacol. 2021;19:1661–87.